科学研究

  • 学术报告:Transcription Re...
    2019-10-16
  • 学术报告:肠道菌群与非酒精...
    2019-09-11
  • 强伯勤先生八十华诞学术报告...
    2019-09-09

会员登录

用户名:
密码:

2017年度论文动态

Red blood cells release microparticles containing human argonaute 2 and miRNAs to target genes of Plasmodium falciparum.

Wang Z1, Xi J1, Hao X1, Deng W1, Liu J1, Wei C1, Gao Y1, Zhang L1, Wang H1.

Emerg Microbes Infect. 2017 Aug 23;6(8):e75. doi: 10.1038/emi.2017.63.
PMID: 28831191

Abstract
Red blood cells (RBCs) are known to function as a refuge for providing food resources and as a shelter against the host's immune system after malaria parasite (Plasmodium) infection. Recent studies have reported significant production of extracellular vesicles (microparticles, MPs) in the circulation of malaria patients. However, it is unclear how these extracellular vesicles are generated and what their biological functions are. In this study, we isolated the MPs from a culture medium of normal RBCs and malaria parasite-infected RBCs (iRBCs), compared their quantity and origins, and profiled their miRNAs by deep sequencing. We found a much larger number of MPs released in the culture of iRBCs than in the culture of normal RBCs. Further investigation indicated that, in these MPs, human argonaute 2 (hAgo2) was found to bind to hundreds of miRNAs. These hAgo2-miRNA complexes were transferred into the parasites, and the expression of an essential malaria antigen, PfEMP1, was downregulated by miR-451/140 through its binding to the A and B subgroups of var genes, a family of genes encoding PfEMP1. Our data suggest for the first time that, through the release of MPs, mature RBCs present an innate resistance to malaria infection. These studies also shed new light on the reason why RBCs' genetic mutation occurs mainly in populations living in intensive malaria endemic areas and on the possibility of using miRNAs as novel medicines for malaria patients.